Member Info for Zendog

It's a pity Johnson wont listen to Redwood.
I dont think we'd be in this mess of rubbish Chinese LFT dependency mess if Redwood had any role in it.

Hope you're right HappyDays, but fear you are trumpeting just another false dawn that you're trumpeting. Until it actually happens it seems Avacta is now firmly in the "disappoints" box -as the SP level and trend seems to show.

cider2go -
The same should have applied for the last 18 months+ but, where was it? ...I can only conclude, they're hopeless at promoting it.

We need to see AVACTA confirm the Avacta LFT picks up Omicron but, has Avacta even got hold of an omicron sample to test its LFT against yet? Based on past record, such an Avacta assessment and announcement may be months away, if it comes at all? I hope they can do it soon - next week - but, I'm not going to hold my breath for it.

Seems like "no news is good news" is an optimistic view of the below? Cant be straight forward, otherwise would have been public by now? Or, have I missed something? I know the wheels of such legal administration turn very slowly but.....FOUR months since saying the work was done......!3rd August RNS - FOUR months ago said:- Further to the Company's announcement of 2 July 2021 in which Rockhopper reported that the Tribunal had informed the Company that it expected to complete its work in July, the Company can confirm it has yet to receive news of the outcome of the process.

Forget ramping and deramping.
The company needs to produce and sell a material quantity of its masks, the the SP will rise because more shares will be bought than sold.

The New Variant provides a opportunity for Avacta to shake off its hopeless performance over its LFT to date:-
Get the Avacta LFT tested against the new variant; prove it still works or, quickly develop a version that does work.
Do this urgently and convincingly and, maybe the tide of sentiment will turn back in Avacta's favour.
And, who know, Avacta might actually start selling some LFTs.

Ref from the June RNS below.

H2 CY 2021 - that means about 7 weeks left. Will the FDA approval come through? If it does will the SP rise? (Or is it priced in already?)

"In line with industry best practice ANGLE does not intend to provide any further updates on communication with FDA regarding the submission whilst the regulatory process is as expected. ANGLE continues to anticipate a regulatory decision from FDA during H2 CY 2021*.

I can only make sense of it by concluding Avacta has an excitable CEO who is very poor at delivery.

It must be getting to the stage where the big Investors in the company must be asking questions?

Confirmation of Avacta's passive ineptitude around its LFT product.

Well, we are now well into autumn 2021. and still no material sales of the LFT.
When Avacta failed to get its LFT product out on sale in 2020 despite the CEO's hype that there would be sales then, I was trolled by the CEO worshippers on this BB. When I said said , perhaps the CEO always meant it was to be in 2021, some seemed to agree - yes, the CEO never really said sales would happen in 2020.
So, here we are again. Maybe CEO Smith really meant there might be material sales by autumn 2022?
What odds on that , still no better than 50:50 , even now?
Why am I posting this? Well, to bring some reality to this BB. I'd hate to think others might read some CEO worship here and invest their money without some non-CEO worship being visible.
(Though it 's noticeable there's not as much CEO worship as there used to be on here. It seems his spell has worn off, even for the previous truest believers)
I'm invested. I originally invested for the cancer treatment and am holding for the chance that comes good. I've made some profit on the LFT hype but, then, stupidly, invested more at higher SP and am now holding large loss relative to purchase price.
Here's hoping the cancer treatment does come good but, the reality of the CEO and Avacta's performance in LFT marketing and true manufacturing, distribution and sales contracting is that the cancer treatment success-hope is definitely just that - a hope.
Good luck Avacta holders and buyers.

I'm really struggling with how positive spin about Avacta can be put on this Abingdon tweet.
To me it just raises the questions - where the hec is Avacta's LFT production line? How has Avacta failed so badly to make use of Abingdon's capacity?

If only Avacta had some semblance of Marketing ability to take advantage of the ability of its LFT. But month sand months and months pass by without any such.

Only one post on this BB today so far (8.00 am0 - months and months of waiting for LFT sales news taking its toll now?

Hope you are right and today's good news was not timed just to hope to offset only more 'i'm excited' 'jam tomorrow' messaging tomorrow.

Mikey279,
I'm sure you're aware but, just in case anyone reading might assume otherwise - if you wait until AS announces shelving of the LFT before you sell, you could well be selling at less than 50p a share. (Unless you think the LFT is already effectively written off within the existing 110 - 120 p SP?).

However , if an RNS next week ahead of the results, what will the RNS be about?
- Confirmation of meeting on 30/9 - odds on favourite
- material sales of Covid LFT - odds against?
- resignation of CEO due to poor delivery against his own promises- odds in the balance ?
- HMG acknowledges AVACTA / LFT test exist ...1000 - 1 ?

I wonder if he'll tell us what he was working night and day on because it seems it wasn't what we thought he said it was.

Good news that the offer was over-subscribed but, seems odd that an offer supposedly to encourage other investors in provided opportunity for Directors to buy shares at 6p?

Time ticking toward 30th September . If there's no announcement of decent LFT sales figures soon (before 30th), the prospective for SP reaction before/on/after 30th ' results and presentation is not good?
The last three or four 'I'm excited' presentations by the CEO have all provoked SP fall?
The sales silence seems ominous. If they had decent sales they would be saying so?